TrialCannabis and cannabinoid research2022

Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

José Alexandre S Crippa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.